{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:22:09Z","timestamp":1791249729042,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.beem.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T06:58:04Z","timestamp":1284361084000},"page":"625-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Metformin treatment for Type 2 diabetes in pregnancy?"],"prefix":"10.1016","volume":"24","author":[{"given":"David","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.beem.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1503\/cmaj.080012","article-title":"Risk of development of diabetes mellitus after diagnosis of gestational diabetes","volume":"179","author":"Feig","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.beem.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International Association of Diabetes and Pregnancy Study Groups (IADPSG) Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0140-6736(02)08599-9","article-title":"Type 2 diabetes in pregnancy: a growing concern","volume":"359","author":"Feig","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.05.002_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/diab.37.5.622","article-title":"Congenital susceptibility to NIDDM. Role of intrauterine environment","volume":"37","author":"Pettitt","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01221950","article-title":"Metformin in the management of pregnant insulin-independent diabetics","volume":"16","author":"Coetzee","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-8227(86)80036-5","article-title":"The management of non-insulin-dependent diabetes during pregnancy","volume":"1","author":"Coetzee","year":"1986","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.2337\/dc07-s223","article-title":"Prevention of type 2 diabetes in women with previous gestational diabetes","volume":"30","author":"Ratner","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.beem.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.2337\/dc07-1282","article-title":"Point: oral hypoglycaemic agents should not be used to treat diabetic women","volume":"30","author":"Jovanovic","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199511093331901","article-title":"Postprandial vs preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy","volume":"333","author":"de Veciana","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1464-5491.2005.01769.x","article-title":"Effect of pregnancy on the pharmacokinetics of metformin","author":"Hughes","year":"2006","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib15","first-page":"483","article-title":"Influence of food on the disposition of the antidiabetic drug metformin in diabetic patients at steady-state","volume":"17","author":"Saffar","year":"1995","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"key":"10.1016\/j.beem.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0149-2918(03)80093-0","article-title":"Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate release metformin to a once-daily extended-release formulation","volume":"25","author":"Fujioka","year":"2003","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.beem.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1742-1241.2008.01733.x","article-title":"The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study","volume":"62","author":"Gao","year":"2008","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.beem.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.2.5763.685","article-title":"Vitamin-B12 status of patients on long-term metformin therapy","volume":"2","author":"Tomkin","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archinte.166.18.1975","article-title":"Risk factors of vitamin B12 deficiency in patients receiving metformin","volume":"166","author":"Ting","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00016340600855946","article-title":"Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome","volume":"86","author":"Carlsen","year":"2007","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"10.1016\/j.beem.2010.05.002_bib21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin vs insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5694\/j.1326-5377.2004.tb06024.x","article-title":"Metformin therapy and diabetes in pregnancy","volume":"180","author":"Simmons","year":"2004","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.beem.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/tera.1420490405","article-title":"Effects of the biguanide class of oral hypoglycaemic agents on mouse embryogenesis","volume":"49","author":"Denno","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.beem.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin sensitizing drugs in the treatment of polycystic ovary syndrome-a reappraisal","volume":"4","author":"Dunalf","year":"2008","journal-title":"Nature Clinical Practice. Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0140-6736(91)91512-S","article-title":"Effects of in-utero exposure to oral hypoglycaemic drugs","volume":"338","author":"Piacquadio","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1464-5491.2007.02053.x","article-title":"A 10 year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose lowering agents","volume":"24","author":"Ekpebegh","year":"2007","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib29","first-page":"179","article-title":"The safety of oral hypoglycaemic agents in the first trimester of pregnancy","volume":"10","author":"Gutzin","year":"2003","journal-title":"The Canadian Journal of Clinical Pharmacology"},{"key":"10.1016\/j.beem.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1464-5491.2006.01856.x","article-title":"Metformin use and diabetic pregnancy\u2014has its time come","volume":"23","author":"Hawthorne","year":"2006","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first trimester exposure to metformin: a meta analysis","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.beem.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","article-title":"Placental passage of metformin in women with polycystic ovary syndrome","volume":"83","author":"Vanky","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.05.002_bib34","first-page":"880","article-title":"Metformin crosses the placenta: a modulator for fetal insulin resistance","volume":"327","author":"Hague","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2010.05.002_bib35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9378(94)90078-7","article-title":"Comparative placental transport of oral hypoglycaemic agents in humans: a model of human placental drug transfer","volume":"171","author":"Elliott","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2010.05.002_bib36","series-title":"Management of women with obesity in pregnancy","author":"Centre for Maternal and Child Enquiries and Royal College of Obstetricians and Gynaecologists","year":"2010"},{"key":"10.1016\/j.beem.2010.05.002_bib37","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/diacare.28.9.2118","article-title":"Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women","volume":"28","author":"Jensen","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycaemic agents in 118 diabetic pregnancies","volume":"17","author":"Hellmuth","year":"2000","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1464-5491.2006.01750.x","article-title":"Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome?","volume":"23","author":"Hughes","year":"2006","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-5491.2009.02780.x","article-title":"Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: case control study","volume":"26","author":"Balani","year":"2009","journal-title":"Diabetes Medicine"},{"key":"10.1016\/j.beem.2010.05.002_bib41","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00125-002-0939-x","article-title":"Transfer of metformin into human milk","volume":"45","author":"Hale","year":"2002","journal-title":"Diabetelogia"},{"key":"10.1016\/j.beem.2010.05.002_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mcp.2003.9","article-title":"Transfer of metformin into human milk","volume":"73","author":"Gardiner","year":"2003","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.beem.2010.05.002_bib43","series-title":"Global guideline: pregnancy and diabetes","author":"International Diabetes Federation","year":"2009"},{"key":"10.1016\/j.beem.2010.05.002_bib44","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/S0140-6736(03)13505-2","article-title":"Effect of a diabetic environment in utero on predisposition to type 2 diabetes","volume":"361","author":"Sobngwi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.05.002_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.05.002_bib46","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2010.05.002_bib47","unstructured":"Medsafe. Datasheet: Metformin. http:\/\/www.medsafe.govt.nz\/Profs\/datasheet\/a\/ArrowMetformintab.htm [accessed 31.03.10]."},{"key":"10.1016\/j.beem.2010.05.002_bib48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Human Reproduction"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:42:38Z","timestamp":1761496958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X10000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1521690X10000357"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.05.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin treatment for Type 2 diabetes in pregnancy?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}